NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 31 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2016. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $47,000 | -44.0% | 18,912 | -18.2% | 0.01% | +60.0% |
Q1 2017 | $84,000 | -9.7% | 23,107 | -34.0% | 0.01% | -16.7% |
Q4 2016 | $93,000 | -7.9% | 35,007 | +13.3% | 0.01% | +20.0% |
Q3 2016 | $101,000 | +14.8% | 30,907 | +17.5% | 0.01% | 0.0% |
Q2 2016 | $88,000 | -62.1% | 26,307 | -72.3% | 0.01% | -66.7% |
Q1 2016 | $232,000 | – | 94,894 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corrigan Financial, Inc. | 302,252 | $102,766 | 0.03% |
Virtu Financial LLC | 13,324 | $5 | 0.00% |
Bleakley Financial Group, LLC | 80,000 | $27,200 | 0.00% |
Beaird Harris Wealth Management, LLC | 24,400 | $8,296 | 0.00% |
One Day In July LLC | 10,000 | $3,400 | 0.00% |
Cubic Asset Management, LLC | 10,000 | $3,400 | 0.00% |
WMS Partners, LLC | 18,000 | $6,120 | 0.00% |
Simplicity Solutions, LLC | 80,000 | $27,200 | 0.00% |
WELLS FARGO & COMPANY/MN | 3,296 | $1,121 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |